Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells (original) (raw)

• Rosenberg, S.A. Immunotherapy and gene therapy of cancer. Cancer Res. 51, 5074s–5079s (1991).
  CAS PubMed Google Scholar
• Melief, C.J. & Kast, W.M. T-cell immunotherapy of tumors by adoptive transfer of cytotoxic T lymphocytes and by vaccination with minimal essential epitopes. Immunol. Rev. 145, 167 –177 (1995).
  Article CAS Google Scholar
• Riddell, S.R. & Greenberg, P.D. Principles for adoptive T cell therapy of human viral diseases. Annu. Rev. Immunol. 13, 545–586 (1995).
  Article CAS Google Scholar
• Rooney, C.M., Heslop, H.E. & Brenner, M.K. EBV specific CTL: a model for immune therapy. Vox Sang. 2, 497–498 ( 1998).
  Article Google Scholar
• O'Reilly, R.J. et al. Adoptive immunotherapy for Epstein–Barr virus-associated lymphoproliferative disorders complicating marrow allografts. Springer Semin. Immunopathol. 20, 455– 491 (1998).
  Article CAS Google Scholar
• Lanzavecchia, A., Lezzi, G. & Viola, A. From TCR engagement to T cell activation: a kinetic view of T cell behavior. Cell 96, 1– 4 (1999).
  Article CAS Google Scholar
• Dustin, M.L. & Shaw, A.S. Costimulation: building an immunological synapse [comment]. Science 283, 649– 650 (1999).
  Article CAS Google Scholar
• Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245– 252 (1998).
  Article CAS Google Scholar
• Grakoui, A. et al. The immunological synapse: a molecular machine controlling T cell activation [see comments]. Science 285, 221–227 (1999).
  Article CAS Google Scholar
• Davis, M.M. & Chien, Y. Topology and affinity of T-cell receptor mediated recognition of peptide–MHC complexes. Curr. Opin. Immunol. 5, 45–49 ( 1993).
  Article CAS Google Scholar
• Lenschow, D.J., Walunas, T.L. & Bluestone, J.A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233–258 (1996).
  Article CAS Google Scholar
• Shaw, A.S. & Dustin, M.L. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 6, 361–369 (1997).
  Article CAS Google Scholar
• Watts, T.H. & DeBenedette, M.A. T cell co-stimulatory molecules other than CD28. Curr. Opin. Immunol. 11, 286–293 (1999).
  Article CAS Google Scholar
• Parra, E., Wingren, A.G., Hedlund, G., Kalland, T. & Dohlsten, M. The role of B7-1 and LFA-3 in costimulation of CD8+ T cells. J. Immunol. 158, 637–642 (1997).
  CAS PubMed Google Scholar
• Fields, P.E. et al. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells. J. Immunol. 161, 5268–5275 (1998).
  CAS PubMed Google Scholar
• Deeths, M.J. & Mescher, M.F. ICAM-1 and B7-1 provide similar but distinct costimulation for CD8+ T cells, while CD4+ T cells are poorly costimulated by ICAM-1. Eur. J. Immunol. 29, 45–53 ( 1999).
  Article CAS Google Scholar
• Bednarek, M.A. et al. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J. Immunol. 147, 4047–4053 ( 1991).
  CAS PubMed Google Scholar
• Morrison, J. et al. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur. J. Immunol. 22, 903– 907 (1992).
  Article CAS Google Scholar
• Kawakami, Y. et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180, 347–352 (1994).
  Article CAS Google Scholar
• Parkhurst, M.R. et al. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. J. Immunol. 157, 2539–2548 (1996).
  CAS PubMed Google Scholar
• Chen, Y.T. et al. Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas. Proc. Natl. Acad. Sci. USA 93, 5915–5919 (1996).
  Article CAS Google Scholar
• Anderson, K. et al. Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen-processing mutant cells to class I-restricted cell-mediated lysis. J. Exp. Med. 174, 489 –492 (1991).
  Article CAS Google Scholar
• Lehner, P.J. & Cresswell, P. Processing and delivery of peptides presented by MHC class I molecules. Curr. Opin. Immunol. 8, 59–67 (1996).
  Article CAS Google Scholar
• Sprent, J., Cai, Z., Brunmark, A., Jackson, M.R. & Peterson, P.A. Constructing artificial antigen-presenting cells from Drosophila cells. Adv. Exp. Med. Biol. 417, 249–254 (1997).
  Article CAS Google Scholar
• Sprent, J. Antigen-presenting cells. Professionals and amateurs. Curr. Biol. 5, 1095–1097 ( 1995).
  Article CAS Google Scholar
• Mellman, I., Turley, S.J. & Steinman, R.M. Antigen processing for amateurs and professionals . Trends Cell Biol. 8, 231– 237 (1998).
  Article CAS Google Scholar
• Spagnoli, G.C. et al. Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients. Int. J. Cancer 64, 309–315 (1995).
  Article CAS Google Scholar
• Rivoltini, L. et al. Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy. J. Immunol. 156, 3882–3891 (1996).
  CAS PubMed Google Scholar
• Kawakami, Y. & Rosenberg, S.A. Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy. Int. Rev. Immunol. 14, 173–192 (1997).
  Article CAS Google Scholar
• Levine, B.L. et al. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J. Immunol. 159, 5921–5930 (1997).
  CAS PubMed Google Scholar
• Brenner, M.K., Heslop, H.E. & Rooney, C.M. Gene and cell transfer for specific immunotherapy . Vox Sang. 2, 87–90 (1998).
  Article Google Scholar
• Heslop, H.E. et al. Long-term restoration of immunity against Epstein–Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes . Nat. Med. 2, 551–555 (1996).
  Article CAS Google Scholar
• Schultze, J.L. et al. CD40-activated human B cells: an alternative source of highly efficient antigen-presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J. Clin. Invest. 100 , 2757–2765 (1997).
• Krause, A. et al. Antigen-dependent CD28 signaling selectively enhances survival and proliferation in genetically modified activated human primary T lymphocytes . J. Exp. Med. 188, 619– 626 (1998).
  Article CAS Google Scholar
• Gong, M.C. et al. Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen. Neoplasia 1, 123–127 (1999).
  Article CAS Google Scholar
• Riviere, I., Brose, K. & Mulligan, R.C. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Proc. Natl. Acad. Sci. USA 92, 6733–6737 (1995).
  Article CAS Google Scholar
• Gallardo, H.F., Tan, C. & Sadelain, M. The internal ribosomal entry site of the encephalomyocarditis virus enables reliable coexpression of two transgenes in human primary T lymphocytes . Gene Ther. 4, 1115–1119 (1997).
  Article CAS Google Scholar
• Ory, D.S., Neugeboren, B.A. & Mulligan, R.C. A stable human-derived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc. Natl. Acad. Sci. USA 93, 11400– 11406 (1996).
  Article CAS Google Scholar
• Riviere, I. & Sadelain, M. In Gene therapy protocols (ed. Robbins, P.D) 59–78 (Humana Press, Totowa, NJ; 1997).
  Google Scholar
• Bender, A., Sapp, M., Schuler, G., Steinman, R.M. & Bhardwaj, N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 196, 121–135 ( 1996).
  Article CAS Google Scholar
• Romani, N. et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J. Immunol. Methods 196, 137–151 (1996).
  Article CAS Google Scholar
• O'Doherty, U. et al. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium. J. Exp. Med. 178, 1067–1076 (1993).
  Article CAS Google Scholar
• Bhardwaj, N. et al. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells . J. Clin. Invest. 94, 797– 807 (1994).
  Article CAS Google Scholar
• Young, J.W. & Steinman, R.M. Dendritic cells stimulate primary human cytolytic lymphocyte responses in the absence of CD4+ helper T cells. J. Exp. Med. 171, 1315– 1332 (1990).
  Article CAS Google Scholar
• Bryant, J., Day, R., Whiteside, T.L. & Herberman, R.B. Calculation of lytic units for the expression of cell-mediated cytotoxicity. J. Immunol. Methods 146, 91–103 (1992).
  Article CAS Google Scholar